No retraction, correction or concern found when last checked on Oct 29, 2026.
Solving structures of protein complexes by molecular replacement with Phaser
Airlie J. McCoy
Acta Crystallographica Section D Biological Crystallography · 2006 · CC BY
Abstract
Molecular replacement (MR) generally becomes more difficult as the number of components in the asymmetric unit requiring separate MR models (i.e. the dimensionality of the search) increases. When the proportion of the total scattering contributed by each search component is small, the signal in the search for each component in isolation is weak or non-existent. Maximum-likelihood MR functions enable complex asymmetric units to be built up from individual components with a ;tree search with pruning' approach. This method, as implemented in the automated search procedure of the program Phaser, has been very successful in solving many previously intractable MR problems. However, there are a number of cases in which the automated search procedure of Phaser is suboptimal or encounters difficulties. These include cases where there are a large number of copies of the same component in the asymmetric unit or where the components of the asymmetric unit have greatly varying B factors. Two case studies are presented to illustrate how Phaser can be used to best advantage in the standard ;automated MR' mode and two case studies are used to show how to modify the automated search strategy for problematic cases.
Cited by papers we hold 28
- An allosteric pan-TEAD inhibitor blocks oncogenic YAP/TAZ signaling and overcomes KRAS G12C inhibitor resistance · 2023No notice
- Peptidomes and Structures Illustrate How SLA-I Micropolymorphism Influences the Preference of Binding Peptide Length · 2022Not checked
- Near-Pan-neutralizing, Plasma Deconvoluted Antibody N49P6 Mimics Host Receptor CD4 in Its Quaternary Interactions with the HIV-1 Envelope Trimer · 2021Not checked
- Putative hexameric glycosyltransferase functional unit revealed by the crystal structure of Acinetobacter baumannii MurG · 2021Not checked
- A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein · 2021No notice
- Crystal structure of Drosophila Piwi · 2020Not checked
- Crystal structure-guided design of berberine-based novel chitinase inhibitors · 2020Not checked
- Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequence · 2019No notice
- A potent broadly neutralizing human RSV antibody targets conserved site IV of the fusion glycoprotein · 2019No notice
- Structure of natural variant transglutaminase 2 reveals molecular basis of gaining stability and higher activity. · 2018Not checked
- Inherent flexibility of CLIC6 revealed by crystallographic and solution studies · 2018Not checked
- IP6 is an HIV pocket factor that prevents capsid collapse and promotes DNA synthesis · 2018No notice
- Design and Characterization of a Human Monoclonal Antibody that Modulates Mutant Connexin 26 Hemichannels Implicated in Deafness and Skin Disorders · 2017Not checked
- Deconstruction of the Ras switching cycle through saturation mutagenesis · 2017No notice
- Structural and functional analysis of the GABARAP interaction motif (GIM) · 2017Corrected
- CryoEM structures of membrane pore and prepore complex reveal cytolytic mechanism of Pneumolysin · 2017No notice
- Structural Basis for a Safety-Belt Mechanism That Anchors Condensin to Chromosomes · 2017No notice
- Crystal structure of an RNA-cleaving DNAzyme · 2017No notice
- Erratum: Comprehensive analysis of antibody recognition in convalescent humans from highly pathogenic avian influenza H5N1 infection · 2016Not checked
- Polycomb repressive complex 2 structure with inhibitor reveals a mechanism of activation and drug resistance · 2016No notice
and 8 more
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.